🟩 Friday's market session delivered a harsh wake-up call for Singapore investors: the Singapore Paincare privatisation deal just collapsed, leaving shareholders staring at potential losses when trading resumes Monday. Meanwhile, the STI slipped 0.4% as investors brace for this week's Fed decision. But here's what the headlines won't tell you—while small-cap deals are falling apart due to tight financing, institutional giants like GIC and Brookfield just dropped $4 billion on Australian real assets. The market isn't crashing; it's differentiating between quality and speculation.
In today's Daily SGX Stock Market Digest, I break down exactly what went wrong with the Singapore Paincare deal, why Rex International's 14% bond coupon is a red flag, and what Sembcorp's bold coal acquisition really means for shareholders. More importantly, I reveal what the massive GIC-Brookfield storage REIT deal tells us about where smart money is flowing right now. Plus, I'll share my specific price targets for the STI and whether you should be buying, selling, or sitting on cash as we head into one of the most volatile weeks of 2025.
Watch the full analysis to discover which SGX stocks still offer value, which sectors to avoid completely, and my exact recommendation for where the STI needs to fall before deploying fresh capital. Don't let deal risk and speculation destroy your portfolio—learn how to separate the wheat from the chaff in today's market. Hit play now!
Comments